Ferraro S, Saielli L, Biganzoli D, Tosi M, Guidi L, Longo R
Nutrients. 2025; 17(2).
PMID: 39861405
PMC: 11767892.
DOI: 10.3390/nu17020274.
Garofalo M, De Simone G, Motta Z, Nuzzo T, De Grandis E, Bruno C
Front Psychiatry. 2024; 15:1408175.
PMID: 39050919
PMC: 11266155.
DOI: 10.3389/fpsyt.2024.1408175.
Maisterrena A, Matas E, Mirfendereski H, Balbous A, Marchand S, Jaber M
Biomolecules. 2022; 12(11).
PMID: 36421705
PMC: 9688008.
DOI: 10.3390/biom12111691.
Montanari M, Martella G, Bonsi P, Meringolo M
Int J Mol Sci. 2022; 23(7).
PMID: 35409220
PMC: 8998955.
DOI: 10.3390/ijms23073861.
Cheung G, Bataveljic D, Visser J, Kumar N, Moulard J, Dallerac G
Nat Commun. 2022; 13(1):753.
PMID: 35136061
PMC: 8826940.
DOI: 10.1038/s41467-022-28331-7.
Autistic-Like Behavior and Impairment of Serotonin Transporter and AMPA Receptor Trafficking in -Ethylmaleimide Sensitive Factor Gene-Deficient Mice.
Xie M, Iwata K, Ishikawa Y, Nomura Y, Tani T, Murata K
Front Genet. 2021; 12:748627.
PMID: 34745222
PMC: 8563833.
DOI: 10.3389/fgene.2021.748627.
Biopsychological correlates of repetitive and restricted behaviors in autism spectrum disorders.
Comparan-Meza M, Vargas de la Cruz I, Jauregui-Huerta F, Gonzalez-Castaneda R, Gonzalez-Perez O, Galvez-Contreras A
Brain Behav. 2021; 11(10):e2341.
PMID: 34472728
PMC: 8553330.
DOI: 10.1002/brb3.2341.
Gene-Environment Interactions in Developmental Neurotoxicity: a Case Study of Synergy between Chlorpyrifos and CHD8 Knockout in Human BrainSpheres.
Modafferi S, Zhong X, Kleensang A, Murata Y, Fagiani F, Pamies D
Environ Health Perspect. 2021; 129(7):77001.
PMID: 34259569
PMC: 8278985.
DOI: 10.1289/EHP8580.
Comparison of the Metabolic Profiles in the Plasma and Urine Samples Between Autistic and Typically Developing Boys: A Preliminary Study.
Xu X, Cai X, Meng F, Song T, Wang X, Wei Y
Front Psychiatry. 2021; 12:657105.
PMID: 34149478
PMC: 8211775.
DOI: 10.3389/fpsyt.2021.657105.
Glutamatergic Dysfunction and Synaptic Ultrastructural Alterations in Schizophrenia and Autism Spectrum Disorder: Evidence from Human and Rodent Studies.
Eltokhi A, Santuy A, Merchan-Perez A, Sprengel R
Int J Mol Sci. 2020; 22(1).
PMID: 33374598
PMC: 7793137.
DOI: 10.3390/ijms22010059.
Assessments of Amino Acids, Ammonia and Oxidative Stress Among Cohort of Egyptian Autistic Children: Correlations with Electroencephalogram and Disease Severity.
Saleem T, Shehata G, Toghan R, Sakhr H, Bakri A, Desoky T
Neuropsychiatr Dis Treat. 2020; 16:11-24.
PMID: 32021195
PMC: 6954634.
DOI: 10.2147/NDT.S233105.
Dietary Considerations in Autism Spectrum Disorders: The Potential Role of Protein Digestion and Microbial Putrefaction in the Gut-Brain Axis.
Sanctuary M, Kain J, Angkustsiri K, German J
Front Nutr. 2018; 5:40.
PMID: 29868601
PMC: 5968124.
DOI: 10.3389/fnut.2018.00040.
Are therapeutic diets an emerging additional choice in autism spectrum disorder management?.
Gogou M, Kolios G
World J Pediatr. 2018; 14(3):215-223.
PMID: 29846886
DOI: 10.1007/s12519-018-0164-4.
Body fluid levels of neuroactive amino acids in autism spectrum disorders: a review of the literature.
Zheng H, Wang W, Li X, Rauw G, Baker G
Amino Acids. 2016; 49(1):57-65.
PMID: 27686223
PMC: 5241332.
DOI: 10.1007/s00726-016-2332-y.
Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension.
Aman M, Findling R, Hardan A, Hendren R, Melmed R, Kehinde-Nelson O
J Child Adolesc Psychopharmacol. 2016; 27(5):403-412.
PMID: 26978327
PMC: 5510039.
DOI: 10.1089/cap.2015.0146.
Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach.
Minshawi N, Hurwitz S, Morriss D, McDougle C
J Autism Dev Disord. 2014; 45(6):1541-68.
PMID: 25395094
DOI: 10.1007/s10803-014-2307-3.
Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children.
West P, Amaral D, Bais P, Smith A, Egnash L, Ross M
PLoS One. 2014; 9(11):e112445.
PMID: 25380056
PMC: 4224480.
DOI: 10.1371/journal.pone.0112445.
The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.
Rojas D
J Neural Transm (Vienna). 2014; 121(8):891-905.
PMID: 24752754
PMC: 4134390.
DOI: 10.1007/s00702-014-1216-0.
Glutamatergic candidate genes in autism spectrum disorder: an overview.
Chiocchetti A, Bour H, Freitag C
J Neural Transm (Vienna). 2014; 121(9):1081-106.
PMID: 24493018
DOI: 10.1007/s00702-014-1161-y.
Increased glutamate and homocysteine and decreased glutamine levels in autism: a review and strategies for future studies of amino acids in autism.
Ghanizadeh A
Dis Markers. 2013; 35(5):281-6.
PMID: 24167375
PMC: 3787567.
DOI: 10.1155/2013/536521.